Evans S M, Jenkins W T, Shapiro M, Koch C J
School of Veterinary Medicine (Clinical Studies), University of Pennsylvania, Philadelphia, USA.
Adv Exp Med Biol. 1997;411:215-25. doi: 10.1007/978-1-4615-5865-1_26.
The presence and significance of tumor hypoxia has been recognized since the 1950's. Hypoxic cells in vitro and in animal tumors in vivo are documented to be three times more resistant to radiation-induced killing compared to aerobic cells. There is now evidence that tumor hypoxia is treatment-limiting in many human cancers. One common way to describe the extent of hypoxia in individual and groups of tumors is the "hypoxic fraction." This measurement infers that cells are present in only two radiobiologically significant states: oxygenated and hypoxic. In this paper, we demonstrate the qualitative and quantitative presence of hypoxic tumor cells using the oxygen dependent metabolism of the 2-nitroimidazole, EF5. Two assumptions concerning the calculation and interpretation of the hypoxic fraction are considered. The first is the use of multiple animals to describe the radiation response at a given radiation dose. We hypothesize that the presence of intertumor variability in radiation response due to hypoxia could negatively influenced the characterization of the change in slope required to calculate the hypoxic fraction. The studies presented herein demonstrate heterogeneity of radioresponse due to hypoxic fraction within and between tumor lines. The 9L subcutaneous tumor studied in air-breathing rats demonstrates a 2 log variation in surviving fraction at 17 Gy. The Morris 7777 hepatoma, in contrast, showed little variability of radiation response. Our second question addresses the limitations of using the "hypoxic fraction" to describe the radiation response of a tumor. This calculated value infers that radiobiological hypoxia is a binary measurement: that a tumor contains two cell populations, aerobic cells with maximal radiosensitivity and hypoxic cells with maximal radioresistance. The classic work of Thomlinson and Gray, however, implies the presence of an oxygen gradient from tumors vessel through the tissues. In both the 9L and Q7 tumors, flow cytometric analysis of EF5 binding demonstrates a continuous range of cellular pO2 levels. These studies suggest that: 1) there is extensive intertumor variability of radiation response in certain tumor lines; 2) the variability in radiation response between individual tumors in a group may affect the ability to describe a particular tumor type's "hypoxic fraction" and 3) The oxygen status of tumor cells is a continuum. This realization affects the ability to apply a binary concept such as the "hypoxic fraction" effectively in radiobiology.
自20世纪50年代以来,肿瘤缺氧的存在及其重要性就已得到认可。体外和体内动物肿瘤中的缺氧细胞被证明对辐射诱导的杀伤作用的抗性是有氧细胞的三倍。现在有证据表明,肿瘤缺氧在许多人类癌症中限制了治疗效果。描述个体肿瘤和肿瘤群体中缺氧程度的一种常见方法是“缺氧分数”。这种测量方法推断细胞仅存在于两种具有放射生物学意义的状态:含氧和缺氧。在本文中,我们利用2-硝基咪唑EF5的氧依赖性代谢,证明了缺氧肿瘤细胞的定性和定量存在。我们考虑了关于缺氧分数计算和解释的两个假设。第一个假设是使用多只动物来描述给定辐射剂量下的辐射反应。我们假设由于缺氧导致的肿瘤间辐射反应变异性的存在可能会对计算缺氧分数所需的斜率变化特征产生负面影响。本文所呈现的研究表明,肿瘤系内和系间由于缺氧分数导致的放射反应存在异质性。在呼吸空气的大鼠中研究的9L皮下肿瘤在17 Gy时存活分数有2个对数的变化。相比之下,Morris 7777肝癌的辐射反应几乎没有变异性。我们的第二个问题涉及使用“缺氧分数”来描述肿瘤辐射反应的局限性。这个计算值推断放射生物学缺氧是一种二元测量:即肿瘤包含两个细胞群体,具有最大放射敏感性的有氧细胞和具有最大放射抗性的缺氧细胞。然而,Thomlinson和Gray的经典研究表明,从肿瘤血管到组织存在氧梯度。在9L和Q7肿瘤中,对EF5结合的流式细胞术分析显示细胞pO2水平呈连续范围。这些研究表明:1)某些肿瘤系中存在广泛的肿瘤间辐射反应变异性;2)一组中个体肿瘤之间的辐射反应变异性可能会影响描述特定肿瘤类型“缺氧分数”的能力;3)肿瘤细胞的氧状态是一个连续体。这一认识影响了在放射生物学中有效应用“缺氧分数”等二元概念的能力。